Page last updated: 2024-10-23

azathioprine and Placenta Diseases

azathioprine has been researched along with Placenta Diseases in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Placenta Diseases: Pathological processes or abnormal functions of the PLACENTA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scott, JR1
Feldbush, TL1
Covault, JM1

Other Studies

1 other study available for azathioprine and Placenta Diseases

ArticleYear
A study of maternal lymphoid organs and the progeny following treatment with immunomodulating agents during pregnancy.
    Clinical and experimental immunology, 1977, Volume: 30, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Azathioprine; BCG Vaccine; Cyclophosphamide; Female; Fetal Death; F

1977